Renal parenchymal cells, tubular epithelial cells (TEC) and/or antigen presenting cells (APC) interact with kidney infiltrating T cells and provide signals that drive, or halt T cell activation. The MRL-Faslpr model is appealing to dissect intrarenal signals that regulate lupus nephritis, and the systemic illness, since it shares features with human lupus. The CD28/CTLA4-B7 family of molecules provides positive and negative signals that regulate T cell activation. There are two newly identified members; 1) the inducible costimulator (ICOS), and its ligand ICOS-L that imparts positive and negative signals that regulate T cell activation, and 2) programmed death-1 (PD-1), and its ligands PD-L1 and PD-L2, that solely deliver negative signals that terminate immune responses. We hypothesize that the ICOS and PD-1 T cell pathways regulate immune responses and disease initiation/progression in lupus nephritis. The overall goal is to dissect the functions of these pathways, and investigate the mechanisms by which renal parenchymal cells, and APC regulate lupus nephritis.
The specific aims are: 1) To determine the temporal expression, magnitude, and localization of the iCOS/ICOS-L and PD-1/PD-L1 molecules during lupus nephritis, and the systemic illness in mice. We will correlate ICOS and PD-1 expression patterns with MRL-Faslpr renal pathology and the systemic illness; determine their regulation on TEC; and compare the intrarenal ICOS and PD-1 pathway expression in several mouse strains with lupus nephritis. 2) To establish whether blocking the ICOS pathway regulates lupus nephritis in MRL (+/- Faslpr) mice. We will determine whether deleting ICOS, and blocking ICOS and ICOS-L in MRL mice alters the tempo and severity of lupus nephritis and the systemic illness; and establishes whether ICOS-L on TEC regulates T cell activation. 3) To establish whether blocking the PD-1 pathway regulates lupus nephritis in MRL mice. We will test the hypothesis that the PD-1 pathway provides a negative regulatory signal to block intrarenal T cell activation. We will determine whether deleting PD-L1, and blocking PD-1/PD-LI/PD-L2 during lupus nephritis in MRL mice, worsens disease. We will determine whether B7-1/B7-2 T cell activation signals over-ride the PD-1 pathway inhibitory signals; establish whether altered nephritis in PD-L1 deficient MRL mice is a result of deleting PD-L1 on leukocytes and/or on renal parenchymal cells; and determine whether TEC expressing PD-L1 inhibit T cell activation. Our ultimate goal is to determine whether ICOS and PD-1 pathways are potential therapeutic targets for lupus nephritis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052369-09
Application #
7249472
Study Section
Pathobiology of Kidney Disease Study Section (PBKD)
Program Officer
Flessner, Michael Francis
Project Start
1998-02-01
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2009-06-30
Support Year
9
Fiscal Year
2007
Total Cost
$330,422
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Menke, Julia; Hsu, Mei-Yu; Byrne, Katelyn T et al. (2008) Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice. J Immunol 181:7367-79
Lucas, Julie A; Menke, Julia; Rabacal, Whitney A et al. (2008) Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice. J Immunol 181:2513-21
Menke, Julia; Zeller, Geraldine C; Kikawada, Eriya et al. (2008) CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. J Am Soc Nephrol 19:1177-89
Menke, Julia; Lucas, Julie A; Zeller, Geraldine C et al. (2007) Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles. J Immunol 179:7466-77
Kelley, Vicki Rubin (2007) Leukocyte-renal epithelial cell interactions regulate lupus nephritis. Semin Nephrol 27:59-68
Zeller, Geraldine C; Hirahashi, Junichi; Schwarting, Andreas et al. (2006) Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus. J Am Soc Nephrol 17:122-30
Schwarting, Andreas; Paul, Kathrin; Tschirner, Stefan et al. (2005) Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice. J Am Soc Nephrol 16:3264-72
Lenda, Deborah M; Stanley, E Richard; Kelley, Vicki R (2004) Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice. J Immunol 173:4744-54
Lenda, Deborah M; Kikawada, Eriya; Stanley, E Richard et al. (2003) Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol 170:3254-62
Kelley, Vicki Rubin; Rovin, Brad H (2003) Chemokines: therapeutic targets for autoimmune and inflammatory renal disease. Springer Semin Immunopathol 24:411-21

Showing the most recent 10 out of 19 publications